epcoritamab
abbvie,genmab
['fil,veral,12', 'epcoritamab', 'dlbcl']
#ash22
abstract 443 - et al. in patients with r/r dlbcl, epcoritamab + r-dhax/c demonstrated high orrs and cmr rates with a manageable safety profile across both transplanted and non-transplanted patients. orr 85%; cmr 67% responses were deep and durable 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL